Ischemia-modified albumin (IMA)
Cardiology Network |
Discuss Ischemia-modified albumin (IMA) further in the WikiDoc Cardiology Network |
Adult Congenital |
---|
Biomarkers |
Cardiac Rehabilitation |
Congestive Heart Failure |
CT Angiography |
Echocardiography |
Electrophysiology |
Cardiology General |
Genetics |
Health Economics |
Hypertension |
Interventional Cardiology |
MRI |
Nuclear Cardiology |
Peripheral Arterial Disease |
Prevention |
Public Policy |
Pulmonary Embolism |
Stable Angina |
Valvular Heart Disease |
Vascular Medicine |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Ischemia-modified albumin (IMA) is a test for ischemia that is based on the observation that the affinity of the N-terminus of human albumin for cobalt is reduced in patients with myocardial ischemia.(1) Preliminary studies suggest that it is a sensitive and early detector of chest pain of ischemic etiology,(1-5) as well as of transient myocardial ischemia peri-PCI.(6),(7)
References
- ref1 PMID 11074321
- ref2 PMID 11238298
- ref3 PMID 12213987
- ref4 PMID 12651810
- ref5 PMID 12651803
- ref6 PMID 11376314
- ref7 PMID 12742986